Current trader consensus assigning an 88.5% implied probability to no new pandemic in 2026 rests on sustained low global transmission of novel pathogens through early June, as tracked by WHO and CDC surveillance. Recent Ebola disease outbreaks caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda prompted a public health emergency of international concern declaration in May yet remain regionally contained without evidence of efficient sustained human-to-human spread beyond affected areas. A limited Andes virus hantavirus cluster linked to cruise ship travel produced only 10 reported cases with three deaths and negligible community transmission risk. COVID-19 activity continues declining across most U.S. states with emergency department positivity below 0.1%, while monitoring of candidates such as H5N1 avian influenza shows no adaptation enabling widespread respiratory transmission. Ongoing genomic and wastewater surveillance supports the market view that no pathogen currently meets pandemic criteria.